The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
Medicare Drug Discount Cards: A Work In Progress This report examines the early experience with the Medicare-Approved Drug Discount Card Program, prices offered by card sponsors, and potential savings for enrollees.
This report, Reactions to the New Medicare Drug Law, produced jointly by a bipartisan team of pollsters from Public Opinion Strategies and Peter D. Hart Research Associates, presents key findings from ten focus groups of people on Medicare in three cities: Pittsburgh, PA; Kansas City, KS, and Washington, DC.
Toplines of selected findings of the March/April 2004 Kaiser Family Foundation Health Poll Report survey that underscores the need to educate seniors about the new Medicare prescription drug program. Survey Toplines (.
A chartpack of selected findings of the March/April 2004 Kaiser Family Foundation Health Poll Report survey that underscores the need to educate seniors about the new Medicare prescription drug program. Survey Chartpack (.
Selected findings from the March/April 2004 Kaiser Family Foundation Health Poll Report survey underscores the need to educate seniors about the new Medicare prescription drug program - both the transitional discount card program that will be go into effect on June 1, 2004 and the full Medicare benefit that begins in January 2006.
Preparing for the Medicare Drug Discount Card Rollout A Conference Call Discussion With Medicare beneficiaries eligible to subscribe to a discount drug card as of May 3 and use them as of June 1, there is little time to clear up any confusion or answer outstanding questions about the program.
This publication reports on the findings from an October 26 focus group discussion with state Medicaid officials on the implications of a Medicare drug benefit for states and dual eligibles. Report (.
This document, prepared by Health Policy Alternatives, Inc., provides a detailed side-by-side comparison of the prescription drug provisions of the Conference Agreement (H.R. 1) passed by the House and Senate in November 2003 and the House (H.R. 1) and Senate (S. 1) Medicare proposals passed in June 2003. Report (.
This issue paper describes the origins of the clawback, the formula by which each state’s clawback amount is calculated, and the clawback’s implications for states and for low-income Medicare beneficiaries. Issue Paper (.
Embargoed for release until:February 26, 2004, 12:00 pm EST For further information contact:Jennifer Morales or Sara Knoll, (202) 347-5270Chris Peacock, (650) 854-9400 NEW KAISER FAMILY FOUNDATION SURVEY SHOWS SENIORSCONFUSED ABOUT MEDICARE RX DRUG LAW Nearly 7 In 10 Seniors Say They Do Not Know Drug LegislationWas Passed and Signed Into Law Washington, D.C.
© 2026 KFF